...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Eligibility for registered accounts in Canada

This is the RVX Management Information Circular dated April 29, 2013 that contains the opinion on Newco elegibility for RRSPs and TFSAs.  Search for TFSA or RRSP to locate the section.

Share
New Message
Please login to post a reply